Vaxxinity, Inc. (VAXX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jul 30, 2026, 4:00 PM EST
Vaxxinity Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -56.93 | -75.22 | -137.18 | -39.96 | -14.22 |
Depreciation & Amortization | 2.23 | 1.68 | 1.1 | 0.72 | 0.11 |
Other Amortization | 0.05 | 0.05 | 0.26 | 0.11 | - |
Loss (Gain) From Sale of Investments | -1.55 | -1.02 | - | - | - |
Stock-Based Compensation | 7.51 | 8.71 | 30.41 | 1.01 | 1.23 |
Other Operating Activities | - | 0.04 | 11.53 | 7 | 0.46 |
Change in Accounts Receivable | - | - | 0.03 | -0.03 | - |
Change in Accounts Payable | -3.51 | 2.1 | 2.17 | -0.27 | -0.45 |
Change in Other Net Operating Assets | -5.03 | 7.72 | 10.68 | -2.5 | 0.6 |
Operating Cash Flow | -57.24 | -55.93 | -80.99 | -33.91 | -12.27 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Capital Expenditures | -0.8 | -1.87 | -1.32 | -1.48 | - |
Investment in Securities | 29.65 | -52.53 | - | - | - |
Investing Cash Flow | 28.84 | -54.39 | -1.32 | -1.48 | - |
Financing Activities
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Short-Term Debt Issued | - | - | - | - | 0.6 |
Long-Term Debt Issued | - | - | 2 | 12.3 | 10.52 |
Total Debt Issued | - | - | 2 | 12.3 | 11.12 |
Short-Term Debt Repaid | - | - | -0.1 | - | - |
Long-Term Debt Repaid | -1.59 | -0.43 | -2.67 | -5.7 | - |
Total Debt Repaid | -1.59 | -0.43 | -2.77 | -5.7 | - |
Net Debt Issued (Repaid) | -1.59 | -0.43 | -0.77 | 6.6 | 11.12 |
Issuance of Common Stock | 0.45 | 0.26 | 71.25 | 0.08 | 0.02 |
Other Financing Activities | - | - | 2.9 | 38.97 | - |
Financing Cash Flow | -1.14 | -0.17 | 196.17 | 66.11 | 11.14 |
Net Cash Flow
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Cash Flow | -29.53 | -110.49 | 113.86 | 30.72 | -1.13 |
Free Cash Flow
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Free Cash Flow | -58.04 | -57.79 | -82.31 | -35.39 | -12.27 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | - | - | -124709.09% | -6353.14% | - |
Free Cash Flow Per Share | -0.46 | -0.46 | -1.07 | -0.54 | -0.36 |
Levered Free Cash Flow | -37.38 | -35.19 | -36.91 | -19.04 | - |
Unlevered Free Cash Flow | -36.99 | -34.92 | -36.65 | -18.41 | - |
Additional Metrics
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash Interest Paid | 0.8 | 0.37 | 0.58 | 0.43 | - |
Change in Working Capital | -8.54 | 9.82 | 12.88 | -2.79 | 0.16 |